LACNOTUZUMAB
UNII 77624NN1TU

Substance Identification & Data

This profile provides standardized clinical and technical data for Lacnotuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 77624NN1TU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1831128-32-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

77624NN1TU

CAS Registry Number

1831128-32-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LACNOTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C80044

National Cancer Institute reference terminology for clinical and research data.

INN ID

10524

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lacnotuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LACNOTUZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN MACROPHAGE COLONY-STIMULATING FACTOR) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .KAPPA.-CHAIN, DIMER

LACNOTUZUMAB [INN]

LACNOTUZUMAB [WHO-DD]